Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease

被引:27
作者
Zhou-wen CHEN
机构
关键词
Nonalcoholic fatty liver disease (NAFLD); Alanine aminotransferase (ALT); Metabolic syndrome (MS);
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
Objective:To investigate the relationship between alanine aminotransferase (ALT) levels and metabolic syndrome (MS) in nonalcoholic fatty liver disease (NAFLD). Methods: A total of 26527 subjects who received medical health checkup in our hospital from January 2005 to July 2007 were enrolled in the study. The diagnosis of fatty liver was based on ultrasound imaging. MS was defined according to the criteria of the Adult Treatment Panel III. ALT, triglyceride (TG), high density lipo-protein cholesterol (HDL-c), fasting plasma glucose (FPG), height, weight, waist circumference (WC), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in each subject to analyze the relationship between MS and ALT activity. Results: (1) The prevalence of NAFLD in men (30.94%) was significantly higher than that in women (15.65%); (2) The incidence of MS in NAFLD (33.83%) was significantly greater than that in non-NAFLD (10.62%); (3) Of the 6470 subjects with NAFLD, in the age-adjusted partial correlation analysis, there were statistically significant correlations between the ALT levels and most metabolic risk factors in each sex (P<0.01), except that ALT levels had no correlation with HDL-c in women. Moreover, in the multiple stepwise regression analysis, SBP lost its significance, and WC, body mass index (BMI), age, DBP, TG and FPG were independently associated with ALT levels in both sexes (P<0.05). HDL-c remained significant and was independently related to ALT levels in men; (4) ALT levels were significantly higher in subjects with MS compared to those without MS (P<0.001). Mean ALT levels increased with the number of MS components in each sex (P<0.05 for trend). Conclusion: We found a strong rela-tionship between ALT levels and MS in NAFLD and revealed that the cluster of MS components might be the predictor for ALT elevations.
引用
收藏
页码:616 / 622
页数:7
相关论文
共 50 条
  • [21] Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease
    Chen, Guanliang
    Ni, Yinhua
    Nagata, Naoto
    Xu, Liang
    Ota, Tsuguhito
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (09):
  • [22] The genetic backgrounds in nonalcoholic fatty liver disease
    Seko Y.
    Yamaguchi K.
    Itoh Y.
    [J]. Clinical Journal of Gastroenterology, 2018, 11 (2) : 97 - 102
  • [23] Lipoprotein metabolism in nonalcoholic fatty liver disease
    Jiang, Zhenghui Gordon
    Robson, Simon C.
    Yao, Zemin
    [J]. JOURNAL OF BIOMEDICAL RESEARCH, 2013, 27 (01): : 1 - 13
  • [24] Iron metabolism in Nonalcoholic Fatty Liver Disease
    James E. Nelson
    Heather Klintworth
    Kris V. Kowdley
    [J]. Current Gastroenterology Reports, 2012, 14 (1) : 8 - 16
  • [25] Extrahepatic Complications of Nonalcoholic Fatty Liver Disease
    Chacko, Kristina R.
    Reinus, John
    [J]. CLINICS IN LIVER DISEASE, 2016, 20 (02) : 387 - +
  • [26] Pharmacological management of nonalcoholic fatty liver disease
    Barb, Diana
    Portillo-Sanchez, Paola
    Cusi, Kenneth
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1183 - 1195
  • [27] Sexual Dimorphisms in Nonalcoholic Fatty Liver Disease
    Musto J.
    Spengler E.K.
    German M.N.
    [J]. Current Hepatology Reports, 2021, 20 (4) : 97 - 107
  • [28] Nutritional therapy for nonalcoholic fatty liver disease
    Dongiovanni, Paola
    Lanti, Claudia
    Riso, Patrizia
    Valenti, Luca
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2016, 29 : 1 - 11
  • [29] Prevalence of Nonalcoholic Fatty Liver Disease and Economy
    Zhu, Jin-Zhou
    Dai, Yi-Ning
    Wang, Yu-Ming
    Zhou, Qin-Yi
    Yu, Chao-Hui
    Li, You-Ming
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (11) : 3194 - 3202
  • [30] Advances in Pediatric Nonalcoholic Fatty Liver Disease
    Mencin, Ali A.
    Lavine, Joel E.
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2011, 58 (06) : 1375 - +